Cargando…

Inflammatory Surrogate Parameters for Predicting Ifosfamide-Induced Neurotoxicity in Sarcoma Patients

Sarcomas compromise a heterogenous group of tumors of a mesenchymal origin. Although treatment options in many solid tumors have evolved over the past decades, the treatment of advanced sarcoma is still based on conventional chemotherapeutic agents. Beside anthracyclines, alkylating agents such as i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmidt, Moritz, Benzler, Katrin, Lauer, Ulrich M., Zender, Lars, Hinterleitner, Clemens, Hinterleitner, Martina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572151/ https://www.ncbi.nlm.nih.gov/pubmed/36233666 http://dx.doi.org/10.3390/jcm11195798

Ejemplares similares

Diagnostic Approaches for Neuroendocrine Neoplasms of Unknown Primary (NEN-UPs) and Their Prognostic Relevance—A Retrospective, Long-Term Single-Center Experience
por: Schmidt, Moritz, et al.
Publicado: (2023)

NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendothelioma
por: Schmidt, Moritz, et al.
Publicado: (2023)

Long‐term remission of small cell lung cancer after reactivation of tuberculosis following immune‐checkpoint blockade: A case report
por: Sirgiovanni, Mattia, et al.
Publicado: (2021)

Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine Malignancies
por: Hinterleitner, Martina, et al.
Publicado: (2021)

Myasthenia gravis as initial presentation of a pancreatic neuroendocrine tumor: A case report
por: Stingu, Elena, et al.
Publicado: (2023)

NUT Carcinoma—An Underdiagnosed Malignancy
por: Lauer, Ulrich M., et al.
Publicado: (2022)

Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression
por: Hinterleitner, Clemens, et al.
Publicado: (2021)

Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression
por: Rittig, Susanne M., et al.
Publicado: (2022)

Platelet-expressed immune checkpoint regulator GITRL in breast cancer
por: Zhou, Yanjun, et al.
Publicado: (2021)

Early Reconstitution of Antibody Secreting Cells after Allogeneic Stem Cell Transplantation
por: Hinterleitner, Martina, et al.
Publicado: (2022)

Serotonin Syndrome Complicating Treatment of Ifosfamide Neurotoxicity With Methylene Blue
por: Snyder, Matthew, et al.
Publicado: (2017)

Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer
por: Hinterleitner, Clemens, et al.
Publicado: (2021)

Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas
por: Hagelstein, Ilona, et al.
Publicado: (2021)

Long-term prognostic factors for PRRT in neuroendocrine tumors
por: Trautwein, Nils Florian, et al.
Publicado: (2023)

Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?
por: Zhou, Yanjun, et al.
Publicado: (2021)

Quality of synthetic speech: perceptual dimensions, influencing factors, and instrumental assessment
por: Hinterleitner, Florian
Publicado: (2017)

B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma
por: Hagelstein, Ilona, et al.
Publicado: (2022)

Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol
por: Werner, Sebastian, et al.
Publicado: (2020)

Evaluation of Dose-Intense Ifosfamide, with and Without Edatrexate, in Adults with Sarcoma
por: Casper, Ephraim S., et al.
Publicado: (1999)

Efficacy of ifosfamide, dacarbazine, doxorubicin and cisplatin in human sarcoma xenografts.
por: Budach, W., et al.
Publicado: (1994)

Hepatitis B Reactivation After Ifosfamide Therapy for Retroperitoneal Sarcoma
por: Chhibar, Purva, et al.
Publicado: (2016)

Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma
por: Requilé, Annelies, et al.
Publicado: (2017)

Party Politics vs. Grievance Politics: Competing Modes of Representative Democracy
por: Flinders, Matthew, et al.
Publicado: (2022)

Extended Texture Analysis of Non-Enhanced Whole-Body MRI Image Data for Response Assessment in Multiple Myeloma Patients Undergoing Systemic Therapy
por: Ekert, Kaspar, et al.
Publicado: (2020)

Acute liver toxicity with ifosfamide in the treatment of sarcoma: a case report
por: Cheung, Michelle CM, et al.
Publicado: (2011)

Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy
por: Miller, Devon, et al.
Publicado: (2022)

Neoadjuvant and adjuvant chemotherapy with doxorubicin and ifosfamide for bone sarcomas in adult and older patients
por: URAKAWA, HIROSHI, et al.
Publicado: (2014)

VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma
por: Moon, Ji Young, et al.
Publicado: (2017)

Doxorubicin and ifosfamide for recurrent renal synovial sarcoma: The first case report in Indonesia
por: Fitra, Ahmad Fathira, et al.
Publicado: (2022)

A Stochastic Version of the Jansen and Rit Neural Mass Model: Analysis and Numerics
por: Ableidinger, Markus, et al.
Publicado: (2017)

Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL
por: Clar, Kim L., et al.
Publicado: (2019)

Conservative treatment followed by chemotherapy with doxorubicin and ifosfamide for cervical sarcoma botryoides in young females
por: Zanetta, G, et al.
Publicado: (1999)

Ifosfamide-based combination chemotherapy in advanced soft-tissue sarcoma: a practice guideline
por: Verma, S., et al.
Publicado: (2007)

A Case of Renal Synovial Sarcoma: Complete Remission was Induced by Chemotherapy with Doxorubicin and Ifosfamide.
por: Park, Soo-Jin, et al.
Publicado: (2004)

Evaluation of Anlotinib Combined with Adriamycin and Ifosfamide as Conversion Therapy for Unresectable Soft Tissue Sarcomas
por: Long, Zuoyao, et al.
Publicado: (2023)

DNAM-1/CD226 is functionally expressed on acute myeloid leukemia (AML) cells and is associated with favorable prognosis
por: Chashchina, Anna, et al.
Publicado: (2021)

Pharmacokinetic parameters of ifosfamide in mouse pre-administered with grapefruit juice or naringin
por: Madrigal-Bujaidar, Eduardo, et al.
Publicado: (2019)

The growing pains of ifosfamide
por: Sprangers, Ben, et al.
Publicado: (2020)

The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA
por: Muenchow, Alina, et al.
Publicado: (2020)

Acquired von Willebrand syndrome is common in infants with systemic-to-pulmonary shunts: Retrospective case-series
por: Icheva, Vanya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q4drr50579jbg10aiiq4fgdtu5